Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BR55 Contrast Enhanced Ultrasound (CEUS) in Characterization of Ovarian Lesions

NCT03493464 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.

NCT NCT03493464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03493464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BR55 Contrast Enhanced Ultrasound (CEUS) in Characterization of Ovarian Lesions
Lead sponsor
Bracco Diagnostics, Inc
Phase
Phase 2
Overall status
Terminated
Start date
December 13, 2018
Completion date
July 31, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer